As our understanding of aging progresses, it becomes increasingly clear that aging is not just about the passage of time. Rather, it involves a complex interplay of molecular, cellular, and systemic alterations. These alterations, often referred to as hallmarks of aging, encompass a wide array of biological changes across various systems in the body. Understanding these systemic alterations is crucial for developing interventions to promote healthier aging and treat age-related diseases. CD BioSciences can provide a comprehensive analysis of the systemic alterations in aging using an interdisciplinary approach, advanced technologies, and a team of senior experts with many years of experience.
Inflammaging is a term used to describe the chronic low-grade inflammation that occurs with aging. It is a key driver of age-related diseases such as cardiovascular disease, neurodegenerative disorders, and cancer.
CD BioSciences offers comprehensive analysis services to investigate the underlying mechanisms of inflammaging. Through advanced omics technologies, such as transcriptomics and proteomics, we elucidate the dynamics of inflammatory pathways and identify potential targets for intervention. Our expertise in analyzing inflammatory biomarkers and immune cell profiling enables a deep understanding of the intricate changes associated with inflammaging, setting the stage for developing targeted therapeutics to mitigate age-related inflammation.
We provide cutting-edge analysis of nutrient-sensing pathways, including mTOR, insulin/IGF-1, and AMP-activated protein kinase (AMPK) signaling. By integrating bioinformatic approaches with experimental data, we uncover the alterations in nutrient sensing that occur with aging, shedding light on the interconnected pathways that influence metabolic homeostasis. Our in-depth analysis paves the way for the identification of novel molecular targets for interventions aimed at restoring nutrient sensing and metabolic balance in aging individuals.
CD BioSciences excels in offering state-of-the-art analysis of gut microbiota composition and function during aging. Through metagenomic and metabolomic profiling, we decipher the changes in microbial diversity, functional potential, and metabolite production associated with aging. Our comprehensive understanding of gut microbiota dysbiosis equips us to explore the intricate links between the microbiome and systemic alterations of aging, opening avenues for targeted interventions to promote healthy aging by modulating the gut microbial ecosystem.
Our proficiency in neuroendocrine analysis allows us to elucidate the intricate neuroendocrine dysregulation that arises with aging.
Utilizing methods including neuroimaging, hormone profiling, and gene expression analysis, CD BioSciences can identify modifications in pivotal neuroendocrine pathways and describe alterations in neurotransmitter levels, hormonal equilibrium, and neural circuitry. Our analysis illuminates the mechanisms responsible for neuroendocrine dysregulation in aging and guides the development of targeted therapies to address age-related neurological disorders.
Studying systemic alterations allows for a comprehensive understanding of how aging affects the body as a whole, rather than focusing on individual organs or pathways in isolation. CD BioSciences is well-positioned to provide valuable analytical services in the field of aging with its expertise, cutting-edge technology, customized solutions, and comprehensive data interpretation and reporting. If you are interested in our services, please feel free to contact us or make an online inquiry.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
CD BioScience is a research service provider focused on aging research, specializing in providing research on aging mechanisms, preclinical drug discovery and development, and the development of healthcare and skincare products.
Copyright © 2024 CD BioSciences. All rights reserved.